PedAM
Pediatric Disease Annotations & Medicines
| Disease | atrial fibrillation |
| Phenotype | |heart failure |
| Sentences | 135 |
| PubMedID- 24054475 | Upstream therapy for atrial fibrillation in heart failure. |
| PubMedID- 22989607 | Incident thromboembolism and heart failure associated with new-onset atrial fibrillation in cancer patients. |
| PubMedID- 24390521 | Prediction of congestive heart failure in patients with non valvular atrial fibrillation. |
| PubMedID- 25947352 | Is risk-benefit of warfarin for atrial fibrillation with heart failure determined by heart failure severity. |
| PubMedID- 20078621 | The prevalence of atrial fibrillation (af) in patients with heart failure (hf) is high, but longitudinal studies suggest that the incidence of af is relatively low. |
| PubMedID- 20347787 | Recent data have emerged that help elucidate the complex genetic and nongenetic pathophysiological mechanisms that contribute to the development of atrial fibrillation in individuals with congestive heart failure. |
| PubMedID- 23908348 | Temporal relationship and prognostic significance of atrial fibrillation in heart failure patients with preserved ejection fraction: a community-based study. |
| PubMedID- 24054478 | atrial fibrillation in heart failure in the older population. |
| PubMedID- 24985070 | Predictors of new onset atrial fibrillation in patients with heart failure. |
| PubMedID- 21135811 | Likewise the role of crt in relatively asymptomatic heart failure patients, those with atrial fibrillation and the benefits of providing an implantable cardioverter defibrillator backup to all crt devices has yet to be clearly defined. |
| PubMedID- 23599743 | The aim of this study was to investigate the correlation between the altered expression of genes involved in the regulation of ion channels in atrial myocytes and the risk of atrial fibrillation (af) in patients with heart failure (hf). |
| PubMedID- 23952994 | In our study we compared effect of cardiac resynchronization therapy (crt) in chronic heart failure (chf) patients with permanent atrial fibrillation (af) and patients with sinus rhythm. |
| PubMedID- 24139523 | Background: risk stratification of atrial fibrillation patients with a congestive heart failure (c), hypertension (h), age >/= 75 (a), diabetes (d), stroke or transient ischemic attack (tia) (s2) (chads2) score of <2 remains imprecise, particularly in women. |
| PubMedID- 20403817 | atrial fibrillation in heart failure is associated with an increased risk of death only in patients with ischaemic heart disease. |
| PubMedID- 25807223 | Recent findings: several randomized control trials and systematic reviews demonstrate the safety and efficacy of atrial fibrillation ablation in patients with heart failure and left ventricular systolic dysfunction. |
| PubMedID- 21809972 | Current data show that rate control and rhythm control are both reasonable strategies for the treatment of atrial fibrillation in heart failure patients. |
| PubMedID- 22368560 | We present such a patient who presented in gross congestive heart failure with atrial fibrillation. |
| PubMedID- 24054483 | Catheter ablation of atrial fibrillation in heart failure. |
| PubMedID- 22795713 | Warfarin may reduce risk of ischemic stroke by preventing atrial fibrillation for patients with heart failure and sinus rhythm. |
| PubMedID- 19861229 | A comparison between monophasic and biphasic defibrillation for the cardioversion of persistent atrial fibrillation in patients with and without heart failure. |
| PubMedID- 21774762 | Ischemic heart disease is the most common cause underlying 1) the development of ventricular fibrillation that results in sudden cardiac death and 2) atrial fibrillation that can lead to heart failure and stroke. |
| PubMedID- 24680244 | Differential impacts of achieved heart rate and achieved dose of beta-blocker on clinical outcomes in heart failure with and without atrial fibrillation. |
| PubMedID- 23585251 | Aims: in congestive heart failure (chf) patients with persistent atrial fibrillation (af), direct current cardioversion (dcc) may reveal participation of tachycardiamediated process to left ventricular (lv) dysfunction by restoring sinus rhythm (sr). |
| PubMedID- 26492311 | Beta-blockers treatment in heart failure with atrial fibrillation - who should we believe. |
| PubMedID- 26320296 | [epidemiology and management of heart failure patients with atrial fibrillation]. |
| PubMedID- 24931393 | New-onset atrial fibrillation in heart failure patients has been associated with increased mortality, but has not been definitively related to clinical heart failure progression. |
| PubMedID- 24054474 | Rhythm control of atrial fibrillation in heart failure. |
| PubMedID- 23014130 | Background: despite adequate rate control, the combination of atrial fibrillation with heart failure (hf) has been shown, in a number of studies, to hasten hf progression. |
| PubMedID- 24464846 | A temporal window of vulnerability for development of atrial fibrillation with advancing heart failure. |
| PubMedID- 21150007 | It is particularly useful in patients of heart failure with atrial fibrillation. |
| PubMedID- 21997580 | The latest european and american guidelines have considered atrial fibrillation patients with heart failure eligible for cardiac resynchronization therapy. |
| PubMedID- 26365943 | Clinical characteristics and predictors of one-year outcome of heart failure patients with atrial fibrillation compared to heart failure patients in sinus rhythm. |
| PubMedID- 26258174 | Catheter ablation for atrial fibrillation in heart failure patients: a meta-analysis of randomized controlled trials. |
| PubMedID- 20613934 | Heart transplant recipients and heart failure patients with atrial fibrillation, a pacemaker, and noncardiovascular functional limitations like osteoarthritis were excluded from this study. |
| PubMedID- 23194489 | Background: heart failure (hf) complicated by atrial fibrillation/flutter (af/afl) is associated with worse outcomes. |